Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study

OBJECTIVES: Limited evidence is available regarding alternative therapeutic agents to vancomycin in treating glycopeptide-susceptible Enterococcus faecium (GSEF) bacteraemia. This study assessed the effectiveness and safety of teicoplanin compared with vancomycin for treating GSEF bacteraemia. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Ryo, Yamamoto, Takehito, Okamoto, Koh, Harada, Sohei, Echizenya, Miho, Tsutsumi, Takeya, Takada, Tappei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154127/
https://www.ncbi.nlm.nih.gov/pubmed/36918748
http://dx.doi.org/10.1093/jac/dkad079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154127/
https://www.ncbi.nlm.nih.gov/pubmed/36918748
http://dx.doi.org/10.1093/jac/dkad079

Ejemplares similares